Search Results
Results found for "Scott Struthers"
Posts (8)
- đź“° GPCR Weekly News, June 17 to 23, 2024
and dynamics of the pyroglutamylated RF-amide peptide QRFP receptor GPR103 Industry News EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
Papasergi-Scott and colleagues has made significant progress in this area 2. Papasergi-Scott, M. M. et al. Time-resolved cryo-EM of G-protein activation by a GPCR.
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
(“Neurocrine Biosciences”) announced 22 November 2021, the applicable waiting period under the Hart-Scott-Rodino
Other Pages (2)
- Scott Struthers | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Scott Struthers R. Scott Struthers, Ph.D., is our co-founder and has served as our President and Chief Executive Officer Struthers co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused Scott Struthers on the web LinkedIn Google Scholar Crinetics Radionetics Dr.
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
His non-academic interests include traveling, scouting out micro-breweries, and collecting beer cans.
